Peregrine Ventures has been named Israel’s most active investor in health technology for 2024 by Startup Nation Central (SNC) in their Health Tech Top 100 Report.
In 2024 alone, Peregrine Ventures made 15 strategic investments in the health technology sector. These investments align with our core mission of improving patient outcomes through innovation, addressing some of healthcare’s most pressing challenges.
At the heart of our investment strategy are three primary pillars: brain (injuries and diseases), cardiovascular, and oncology. Peregrine builds clusters of complementary technologies, addressing each field through diverse approaches such as pharmaceuticals, therapeutic medical devices, digital health, and robotics.
We are proud to collaborate with the brightest minds and innovators in Israel’s health tech ecosystem, a global hub for medical breakthroughs. This recognition reaffirms our dedication to identifying and nurturing cutting-edge companies that address critical unmet needs in healthcare.
We extend our deepest gratitude to our portfolio companies and partners for their trust and collaboration. Together, we are shaping the future of healthcare.
